The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

NCT00034749 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Risperidone

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.